IO Biotech
-
2014
Company Description
IO Biotech ApS is a clinical stage biotech company developing disruptive immune therapies i.e. checkpoint/cancer vaccines.
IO Biotech ApS is a clinical stage biotech company developing disruptive immune therapies i.e. checkpoint/cancer vaccines. Checkpoint/cancer vaccines suppress the function of regulatory immune cells and induce inflammation in the microenvironment in addition to direct targeting of cancer cells.
-
Manufacturer:
Science and Engineering -
Formed:
2014 -
Founders:
Per Straten -
Company Website:
-
Company E-mail:
-
Company Address:
IO Biotech ApS Ole Maaløes Vej 3CopenhagenDenmark -
CEO:
- Per Straten
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits